Method of judging risk for onset of druginduced granulocytopenia

Details for Australian Patent Application No. 2004259952 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Hasegawa, Kouichi; Suematsu, Koji

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004259952

PCT Pub. Number WO2005/010183

Priority 2003-281937 29.07.03 JP

Filing date 28 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 16 October 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/010183 Priority application(s): WO2005/010183

16 October 2008 Application Accepted

  Published as AU-B-2004259952

12 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259960-Water-absorbent resin composition and method for producing thereof, and absorbent material and absorbent product using thereof

2004259945-Scroll type fluid machinery